FDA Inspection

SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)June 22, 2011

FDA Inspection 736162 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - June 22, 2011

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals), with an inspection on June 22, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
Inspection Date: June 22, 2011
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 9bd6598d-06ea-4432-a764-dfef23c024fb